| Symbol |
Name |
|
AFF2
|
AF4/FMR2 family, member 2
|
|
APOE
|
apolipoprotein E
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATR
|
ATR serine/threonine kinase
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
CAMK4
|
calcium/calmodulin-dependent protein kinase IV
|
|
CAPRIN1
|
cell cycle associated protein 1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CPEB1
|
cytoplasmic polyadenylation element binding protein 1
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CSMD1
|
CUB and Sushi multiple domains 1
|
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2
|
|
DAB1
|
Dab, reelin signal transducer, homolog 1 (Drosophila)
|
|
DCLRE1B
|
DNA cross-link repair 1B
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FANCI
|
Fanconi anemia, complementation group I
|
|
FHIT
|
fragile histidine triad
|
|
FMR1
|
fragile X mental retardation 1
|
|
FRA11A
|
fragile site, folic acid type, rare, fra(11)(q13.3)
|
|
FRA16D
|
fragile site, aphidicolin type, common, fra(16)(q23.2)
|
|
FRA1E
|
fragile site, aphidicolin type, common, fra(1)(p21.2)
|
|
FRA1H
|
fragile site, 5-azacytidine type, common, fra(1)(q42)
|
|
FRA2G
|
fragile site, aphidicolin type, common, fra(2)(q31)
|
|
FRAXA
|
fragile site, folic acid type, rare, fra(X)(q27.3) A (macroorchidism, mental retardation)
|
|
FXR1
|
fragile X mental retardation, autosomal homolog 1
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
GRM5
|
glutamate receptor, metabotropic 5
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1
|
|
IL10
|
interleukin 10
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KRT14
|
keratin 14, type I
|
|
KRT5
|
keratin 5, type II
|
|
LMNA
|
lamin A/C
|
|
MCRS1
|
microspherule protein 1
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
POLH
|
polymerase (DNA directed), eta
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PROP1
|
PROP paired-like homeobox 1
|
|
RCAN1
|
regulator of calcineurin 1
|
|
RECQL
|
RecQ helicase-like
|
|
RET
|
ret proto-oncogene
|
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F
|
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SPG20
|
spastic paraplegia 20 (Troyer syndrome)
|
|
SPIDR
|
scaffolding protein involved in DNA repair
|
|
STAU1
|
staufen double-stranded RNA binding protein 1
|
|
TARDBP
|
TAR DNA binding protein
|
|
TDRD3
|
tudor domain containing 3
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
|
TERT
|
telomerase reverse transcriptase
|
|
TMEM185A
|
transmembrane protein 185A
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WWOX
|
WW domain containing oxidoreductase
|
